STAT Plus Why Gileads new CEO is a solid choice to help the biotech grow again

STAT Plus: Why Gilead’s new CEO is a solid choice to help the biotech grow again

Gilead Sciences has a new CEO: an A-list pharma veteran and one of the industry’s most successful marketers of cancer drugs.

More From BioPortfolio on "STAT Plus: Why Gilead’s new CEO is a solid choice to help the biotech grow again"